Skip to main content
Premium Trial:

Request an Annual Quote

Diagnostic Hybrids Licenses HIV PGx Technology from Case Western

NEW YORK (GenomeWeb News) – Diagnostic Hybrids this week announced that it has licensed exclusive worldwide rights from Case Western Reserve University to pharmacogenomics test technology for monitoring HIV treatment.

The Athens, Ohio-based firm licensed novel yeast-based virus cloning technology invented by Eric Arts, an associate professor of medicine in the division of infectious diseases, department of medicine, at Case Western Reserve School of Medicine. It said that the technology can monitor the success of HIV treatments by determining drug resistance and disease "strength" of the virus.

Diagnostic Hybrids and Case Western were awarded a $5 million grant last year from the Ohio Third Frontier Biomedical Research and Commercialization Program to accelerate commercial development of a suite of diagnostic products for HIV, hepatitis, and influenza using the yeast vector technology.

Financial and other terms of the license were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.